Evidence map›Paper›PMID 31930029›Full record

ArticleAnnals of translational medicine2019

Gal-1 regulates dendritic cells-induced Treg/Th17 balance though NF-κB/RelB-IL-27 pathway.

Hao Lu, Xinzheng Dai, Xu Li, Yu Sun, Yangjuan Gao, Chuanyong Zhang

Open access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Annals of translational medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hao LuDepartment of Liver Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China.
Xinzheng DaiDepartment of Liver Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China.
Xu LiDepartment of Liver Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China.
Yu SunDepartment of Liver Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China.
Yangjuan GaoDepartment of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China.
Chuanyong ZhangDepartment of Liver Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China.
Nanjing Medical University · CNJiangsu Province Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to investigate the mechanism of galectin (Gal)-1 of regulating Treg/Th17 in pathogenesis of acute rejection after liver transplantation in rat.

methodsMononuclear cells were induced to immature dendritic cells (imDCs), which were transfected with or without NF-κB/RelB. Western Blot was performed to detect the expression of NF-κB/RelB. the expression of CD11c, CD45RB, CD80 and MHC II were detected by flow cytometry. Enzyme-linked immunosorbent assay (ELISA) was employed to detect cytokines IL-27 and TGF-β. Lewis and dark agouti (DA) rats were generally anaesthetized by isoflurane inhalation to establish liver transplant models.

resultsWe demonstrate that Gal-1 disturbs maturation of imDCs by downregulating NF-κB/RelB expression, and Gal-1 negatively controls CD4

conclusionsIn aggregate, Gal-1 promotes Treg differentiation in CD4

Indexed as

acute rejectionLiver transplantationNF-κB/RelBregulatory T cells (Treg cells)Th17 cells

Identifiers

PMID31930029
PMCPMC6944572
OpenAlexW2990828613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.